How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases — Carlo Piccinni (2022) | RDL Network
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases
Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek‐Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Professor Gregory Lip
Vera Maria Avaldi, Jacopo Lenzi, Ilaria Castaldini, Stefano Urbinati, Giuseppe Di Pasquale, Mara Morini, Adalgisa Protonotari, Aldo Maggioni, Maria Pia Fantini
Discussion(0)
No comments yet. Be the first to comment.